@FierceMedDev: Chrono Therapeutics snares $32M in Series A money for wearable smoking cessation device. More | Follow @FierceMedDev
@StacyALawrence: Mobile medical app brings laboratory testing to the home. Story | Follow @StacyALawrence
@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: C.R. Bard wins unanimous FDA panel vote for drug-eluting balloon catheter. Article | Follow @EmilyWFierce
> A mind-controlled robotic suit developed by a Brazilian scientist at Duke helped 29-year-old paraplegic Juliano Pinto kick off the World Cup yesterday. Story
> A med tech development center opened under the joint cooperation of Singapore and South Korea, with companies and local partners able to tap a $5 million fund. More
> The FDA has revised its guidance on magnetic resonance diagnostic devices for better risk compliance. Documents
Biotech News
@FierceBiotech: What's next in diabetes drugs? The pulse of R&D at ADA14. More | Follow @FierceBiotech
@JohnCFierce: Vertex down about 8% now as this Porges note rattles investors. Story | Follow @JohnCFierce
@DamianFierce: Check out FierceBiotech's full 2014 ADA coverage here. | Follow @DamianFierce
> Once-monthly MS drug from Biogen Idec, AbbVie clears Phase III hurdle. More
> Boehringer, Lilly creep up on Sanofi with Lantus biosimilar. Story
> Sanofi's Lantus heir beats its forebear in controlling diabetes. Article
Pharma News
@FiercePharma: Top-read on FP this weekend: Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.Story | Follow @FiercePharma
@TracyStaton: Trending now @FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton
@EricPFierce: In Allergan and Valeant takeover fight, silence is Goldman. More | Follow @EricPFierce
@CarlyHFierce: ICYMI--NYT: Goldman Sachs caught in the middle of Valeant, Allergan takeover fight. Article | Follow @CarlyHFierce
@JustinHFierce: PetVivo ($PETV) updates study on Kush medical device to treat animal osteoarthritis with Gel-Del, CEO Lai: "Mobility." Release | Follow @JustinHFierce
> Could Pfizer nab AstraZeneca with pipeline-based payouts? Maybe, but cash is easier. Story
> Sources: Bayer, J&J's Xarelto faces first U.S. lawsuits. More
CRO News
> InVentiv, Oncobiologics kick off their biosimilar alliance, target Humira. More
> Karyopharm taps CRO Veristat for cancer R&D. Story
> Quintiles signs an expansive deal to chart effects of physical therapy. Article
> Korean pharma booster recruits Novotech to boost local R&D. Report
> After a year of dealmaking, PRA settles in with a new identity. News
Biotech IT News
> EMA backtracks on clinical trial data download ban. News
> Illumina working to turn smartphones into 'molecular stethoscopes.' More
> Google inks deal with Autism Speaks, commits to housing 10,000 whole genomes. Article
> Pfizer strikes tech-enabled drug discovery deal with X-Chem. Story
> AstraZeneca sponsors diabetes patient registry. More